Latest Ipsen News & Updates

See the latest news and media coverage for Ipsen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Ipsen

Global specialty biopharmaceutical company

ipsen.com
Headquarters
Paris, France
Company type
Public company
Number of employees
6,500–10,000

Last updated

Latest news about Ipsen

In short: Ipsen achieved strong financial growth in early 2026, confirmed its annual guidance, and secured European approval for the pediatric drug Ojemda.

Company announcements

  • Ipsen

    Ipsen delivers strong Q1 2026 sales

    Total sales grow 22.6% at CER. Confirms full-year guidance. Expects three Phase III readouts in H2.

  • Ipsen

    Ipsen announces EU approval of Ojemda

    The EC granted conditional marketing authorization for tovorafenib for children six months and older with relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration.

  • Ipsen

    Ipsen announces Beech Tree exemption from tender offer

    Beech Tree, holding 26.03% of Ipsen shares, received exemption from French AMF due to stake transfer to Alasol Foundation, with governance agreement.

  • Ipsen

    Ipsen provides clarifications on Henri Beaufour succession

    Beech Tree, Altawin, and Fondation Alasol enter governance agreement ensuring share retention and non-interference in management. Awaits AMF waiver.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Ipsen

Track Ipsen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.